The global 3d printed drugs market size is evaluated at USD 368.18 million in 2025 and is forecasted to hit around USD 789.2 million by 2034, growing at a CAGR of 8.84% from 2025 to 2034. The North America market size accounted for USD 128.55 million in 2024 and is expanding at a CAGR of 8.86% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1. Introduction
2. Executive Summary
3. Market Dynamics
4. 3D Printed Drugs Market Segments
By Technology
By Application
By End-use
By Geography
5. Cross-sectional Analysis
By Technology
· Inkjet Printing
· Fused Deposition Modeling
· Stereolithography
· Zip Dose Technology
By Application
· Orthopedics
· Neurology
· Dental
· Others
By End-use
· Hospitals & Clinics
· Research Laboratories
· Others
By Geography
· North America
· Asia Pacific
· Europe
· Latin America
· Middle East & Africa
6. Go-to-Market Strategies
7. Competition Analysis
8. Opportunity Assessment
9. New Product Development
10. Plan Finances/ROI Analysis
11. Supply Chain Intelligence/Streamline Operations
12. Cross-border Intelligence
13. Business Model Innovation
14. Blue Ocean vs. Red Ocean Strategies
15. Integration of AI in the 3D Printed Drugs Market
16. Production and Consumption Data
17. Company Profiles
18. Strategic Recommendations
19. Appendix
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client